living drug, as the t-cells from the patients are re-engineered for creating special antigen receptors.
Moreover, immunotherapy is also useful treatment for autoimmune disease, combined immunodeficiency,
inflammatory diseases and some other biological infectious diseases.
The global immunotherapy market is driven by Increasing number of patients with lifestyle related illnesses
and preference for targeted therapies, which cause minimal side effects. Immunotherapy is gaining
importance as an alternative frontline treatment for cancer patients, who are averse to the serious side
effects related to the chemotherapy. Increasing number of cancer patients, minimal side effects and
increasing awareness among patients are the major factors that are expected to drive the growth of the
global immunotherapy drugs market during the forecast period.
The combination of an immunity checkpoint inhibitor with common cold virus has led to a better immune
response among some advanced melanoma patients. The undergoing research programmes related to
immunotherapy are expected to yield new drugs and effective treatments for multiple sclerosis,
mesothelioma, paralysis and other diseases during the forecast period. High cost involved in the
manufacturing of immunotherapy drugs is a major challenge for the major players in the market. The high
cost of the immunotherapy treatment and high depreciation related to the product cycle are the major
restraints for the growth of the global immunotherapy market. Emerging markets are expected to provide
opportunities for major players in the global immunotherapy market to expand, due to the increasing
demand for alternatives for conventional cancer treatments that are very costly.
Segments Covered:
The report segments the global immunotherapy market by product, disease condition and region. On the
basis of product, the market is segmented as monoclonal antibodies, checkpoint inhibitors, vaccines,
inferon’s and others. Based on disease condition, the market is segmented as cancer, infectious disease,
autoimmune disease, and others. Cancer segment has the highest share in the global immunotherapy drugs
Infinium Global Research